Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-conjugating enzyme E2 D3 pseudogene 2 (UBE2D3P2) is a classified pseudogene in the human genome, identified by the gene ID 100130139[3][5]. Unlike protein-coding genes, pseudogenes are typically non-functional genomic sequences similar to normal genes but usually contain mutations that preclude protein expression. UBE2D3P2 does not encode an active protein and is not implicated as a functional molecular target in drug discovery or disease processes. There are no associated biological functions, disease roles, or known drug interactions derived from current scientific sources[5][3]. UBE2D3P2 is a non-coding pseudogene, not a protein-coding enzyme or therapeutic target, and has no established role in human biology or pharmacology[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 D3 pseudogene 2 (UBE2D3P2).